Assignee
GRUENENTHAL CHEMIE
DE·28 granted patents·50 pending applications·494 citations·filing 1973–2020
Top patents by PatentIndex Score
78 records- 0198US7776314B2Abuse-proofed dosage systemGRUENENTHAL CHEMIE·Filed 2004·Granted Aug 17, 2010·300 cites·12 claims
- 0294US7838034B2Intravenous pharmaceutical form of administrationGRUENENTHAL CHEMIE·Filed 2005·Granted Nov 23, 2010·18 cites·12 claims
- 0393US7141695B2Methods for producing substituted acrylic acid esters and use of the latter for producing substituted γ-amino acidsGRUENENTHAL CHEMIE·Filed 2004·Granted Nov 28, 2006·49 cites·11 claims
- 0492US7611730B2Tramadol-based medicamentGRUENENTHAL CHEMIE·Filed 2003·Granted Nov 3, 2009·50 cites·53 claims
- 0588US6875447B2Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac saltGRUENENTHAL CHEMIE·Filed 2003·Granted Apr 5, 2005·22 cites·29 claims
- 0680US6956055B2Substituted γ-lactone compounds as NMDA-antagonistsGRUENENTHAL CHEMIE·Filed 2004·Granted Oct 18, 2005·14 cites·44 claims
- 0776US7109214B2Substituted cyclopentene compoundsGRUENENTHAL CHEMIE·Filed 2004·Granted Sep 19, 2006·10 cites·51 claims
- 0874US7041662B2Substituted benzo [b] azepin-2-one compoundsGRUENENTHAL CHEMIE·Filed 2004·Granted May 9, 2006·8 cites·15 claims
- 0974US2020299225A1Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenolGRUENENTHAL CHEMIE·Filed 2020·Application pending·0 cites
- 1073US2010151028A1Crush resistant delayed-release dosage formsGRUENENTHAL CHEMIE·Filed 2009·Application pending·0 cites
- 1171US6943181B2Use of substituted gamma-lactone compounds as pharmaceutical preparationsGRUENENTHAL CHEMIE·Filed 2004·Granted Sep 13, 2005·5 cites·20 claims
- 1271US2019263747A1Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenolGRUENENTHAL CHEMIE·Filed 2019·Application pending·0 cites
- 1371US2020399252A13-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivativesGRUENENTHAL CHEMIE·Filed 2020·Application pending·0 cites
- 1471US2019029976A1Abuse-proofed dosage formGRUENENTHAL CHEMIE·Filed 2018·Application pending·0 cites
- 1571US2019142767A1Abuse-proofed oral dosage formGRUENENTHAL CHEMIE·Filed 2019·Application pending·0 cites
- 1669US6909017B2Method for isolating and purifying (1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanolGRUENENTHAL CHEMIE·Filed 2003·Granted Jun 21, 2005·3 cites·28 claims
- 1769US2009312296A1Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseasesGRUENENTHAL CHEMIE·Filed 2009·Application pending·0 cites
- 1869US2008247959A1Form of administration secured against misuseGRUENENTHAL CHEMIE·Filed 2008·Application pending·0 cites
- 1969US2008311187A1Crush resistan delayed-release dosage formGRUENENTHAL CHEMIE·Filed 2008·Application pending·0 cites
- 2068US2014378706A1Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenolGRUENENTHAL CHEMIE·Filed 2014·Application pending·0 cites
- 2168US2013171075A1Abuse-proofed dosage formGRUENENTHAL CHEMIE·Filed 2012·Application pending·0 cites
- 2268US2008248113A1Abuse-proofed oral dosage formGRUENENTHAL CHEMIE·Filed 2008·Application pending·0 cites
- 2367US2009258948A1Pharmaceutical saltsGRUENENTHAL CHEMIE·Filed 2009·Application pending·0 cites
- 2467US2014080858A1Abuse-proofed dosage formsGRUENENTHAL CHEMIE·Filed 2013·Application pending·0 cites
- 2567US2014093559A1Abuse-proofed dosage formGRUENENTHAL CHEMIE·Filed 2013·Application pending·0 cites
- 2666US10519176B2Crystalline formsGRUENENTHAL CHEMIE·Filed 2017·Granted Dec 31, 2019·0 cites·15 claims
- 2766US7064236B2Substituted 1-aryl-but-3-enylamine and 1-aryl-but-2-enylamine compoundsGRUENENTHAL CHEMIE·Filed 2004·Granted Jun 20, 2006·2 cites·34 claims
- 2866US2009005408A1Process for the production of an abuse-proofed dosage formGRUENENTHAL CHEMIE·Filed 2008·Application pending·0 cites
- 2966US2013195935A1Abuse-proofed dosage formGRUENENTHAL CHEMIE·Filed 2013·Application pending·0 cites
- 3065US10323052B2Crystallization method and bioavailabilityGRUENENTHAL CHEMIE·Filed 2017·Granted Jun 18, 2019·0 cites·20 claims
- 3165US2008311197A1Process for the production of an abuse-proofed dosage formGRUENENTHAL CHEMIE·Filed 2008·Application pending·0 cites
- 3265US2013251643A1Abuse-proofed oral dosage formGRUENENTHAL CHEMIE·Filed 2013·Application pending·0 cites
- 3364US10093691B2Crystallization method and bioavailabilityGRUENENTHAL CHEMIE·Filed 2016·Granted Oct 9, 2018·0 cites·5 claims
- 3464US2014086847A1Dosage form that is safeguarded from abuseGRUENENTHAL CHEMIE·Filed 2013·Application pending·0 cites
- 3563US2009247530A1Substituted 4-aminocyclohexane derivativesGRUENENTHAL CHEMIE·Filed 2009·Application pending·0 cites
- 3663US2008317854A1Process for the production of an abuse-proofed solid dosage formGRUENENTHAL CHEMIE·Filed 2008·Application pending·0 cites
- 3763US2020331864A11,3-diaza-spiro-[3.4]-octane derivativesGRUENENTHAL CHEMIE·Filed 2020·Application pending·0 cites
- 3861US7217729B2Substituted indoles, process for the production thereof and use thereof for combatting painGRUENENTHAL CHEMIE·Filed 2004·Granted May 15, 2007·1 cites·53 claims
- 3961US2014194455A1Oxidation-stabilized tamper-resistant dosage formGRUENENTHAL CHEMIE·Filed 2014·Application pending·0 cites
- 4059US10526358B2Crystalline formsGRUENENTHAL CHEMIE·Filed 2018·Granted Jan 7, 2020·0 cites·18 claims
- 4159US2008125475A1Mixed ORL1/mu-agonists for the treatment of painGRUENENTHAL CHEMIE·Filed 2007·Application pending·0 cites
- 4259US2005058706A1Delayed release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenolGRUENENTHAL CHEMIE·Filed 2004·Application pending·0 cites
- 4359US2013225697A1Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymerGRUENENTHAL CHEMIE·Filed 2013·Application pending·0 cites
- 4459US2010260833A1Abuse-proofed dosage formGRUENENTHAL CHEMIE·Filed 2010·Application pending·0 cites
- 4556US2020268748A1Tamper-resistant dosage form with immediate release and resistance against solvent extractionGRUENENTHAL CHEMIE·Filed 2020·Application pending·0 cites
- 4656US2009215828A1Substituted indole derivativesGRUENENTHAL CHEMIE·Filed 2009·Application pending·0 cites
- 4755US7557218B2Hydrates of optionally substituted 2-(2-pyridinyl) methylthio-1H-benzimidazoles and process for the production thereofGRUENENTHAL CHEMIE·Filed 2008·Granted Jul 7, 2009·0 cites·9 claims
- 4853US4067985ALactum drug compositionsGRUENENTHAL CHEMIE·Filed 1975·Granted Jan 10, 1978·3 cites·28 claims
- 4953US2011020451A1Tamper-resistant dosage form for oxidation-sensitive opioidsGRUENENTHAL CHEMIE·Filed 2010·Application pending·0 cites
- 5052US2009264387A1Estra-1,3,5(10)-triene derivatives for contraceptionGRUENENTHAL CHEMIE·Filed 2009·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GRUENENTHAL CHEMIE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →